Early and accurate diagnosis of COPD is crucial for effective management. Nanotechnology offers innovative diagnostic tools that can detect COPD at an early stage. For example, nanoparticles can be engineered to target specific biomarkers associated with COPD. When these nanoparticles are introduced into the body, they bind to these biomarkers, allowing for their detection using various imaging techniques.
Moreover, nanotechnology-based sensors can be integrated into wearable devices to monitor lung function and detect changes in respiratory patterns. These sensors are highly sensitive and can provide real-time data, enabling continuous monitoring and early intervention.
